Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS

S Geoffron; Sophie Geoffron; Jérémie F. Cohen; J Cohen; M Sauvan; Guillaume Legendre; G Legendre; Jean‐Michel Wattier; J M Wattier; Émile Daraï; E Daraï; H Fernandez; Nathalie Chabbert‐Buffet; N Chabbert-Buffet

doi:10.1016/j.gofs.2018.02.011

Traitement médical de l’endométriose : prise en charge de la douleur et de l’évolution des lésions par traitement hormonal. RPC Endométriose CNGOF-HAS

S Geoffron, Sophie Geoffron, Jérémie F. Cohen, J Cohen, M Sauvan, Guillaume Legendre, G Legendre, Jean‐Michel Wattier, J M Wattier, Émile Daraï, E Daraï, H Fernandez, Nathalie Chabbert‐Buffet, N Chabbert-Buffet

Gynecologie, obstetrique, fertilite & senologie · 2018 · vol. 46(3) , pp. 231–247 · doi:10.1016/j.gofs.2018.02.011 · PMID:29530557 · W2790065268

review OA: closed CC0 ⤵ 6 in-corpus citations

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This paper discusses the medical management of endometriosis, focusing on hormonal treatment for pain and lesion progression.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004414mesh:D004715mesh:D017699

MeSH descriptors

Contraceptives, Oral Endometriosis Intrauterine Devices, Medicated Dyspareunia Dyspareunia Dyspareunia Endometriosis Female Humans Pelvic Pain Pelvic Pain Pelvic Pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (91)

Cited by (6)

Source provenance

europepmc: last seen: 2026-06-04T01:30:01.192114+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-13T22:19:55.107525+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] Abdominal wall endometriosis following cesarean section: a study of the growth rate of parietal endometriosis implants via openalex

[2] A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. via openalex

[3] A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis via openalex

[4] Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis via openalex

[5] A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg via openalex

[6] A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III–IV endometriosis via openalex

[7] Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study via openalex

[8] Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies via openalex

[9] Clinical characteristics of catamenial and non‐catamenial thoracic endometriosis‐related pneumothorax via openalex

[10] Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis via openalex

[11] Comparison of ovarian cyst formation in women using the levonorgestrel‐releasing intrauterine system vs. hysterectomy via openalex

[12] Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen via openalex

[13] Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex

[14] Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review via openalex

[15] Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study via openalex

[16] Depot medroxyprogesterone acetate versus an oral contraceptive combined with very-low-dose danazol for long-term treatment of pelvic pain associated with endometriosis via openalex

[17] Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment via openalex

[18] Effective post-laparoscopic treatment of endometriosis with dydrogesterone via openalex

[19] Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue via openalex

[20] Effects of Triptorelin Versus Placebo on the Symptoms of Endometriosis via openalex

[21] Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis via openalex

[22] Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis via openalex

[23] Endometriosis via openalex

[24] Endometriosis: Diagnosis and Management via openalex

[25] Endometriosis: Diagnosis and Management via openalex

[26] Gonadotrophin - releasing hormone analogues for endometriosis: bone mineral density via openalex

[27] Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density via openalex

[28] Gonadotrophin-releasing hormone analogues for pain associated with endometriosis via openalex

[29] Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis via openalex

[30] Hormonal therapy after the operation for catamenial pneumothorax – is it always necessary? via openalex

[31] Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery via openalex

[32] Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial via openalex

[33] Levonorgestrel‐releasing intrauterine system (Mirena <sup>®</sup> ) and Depot medroxyprogesterone acetate (Depoprovera) as long‐term maintenance therapy for patients with moderate and severe endometriosis: A randomised controlled trial via openalex

[34] Long‐term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta‐analysis via openalex

[35] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[36] Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex

[37] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[38] Multidisciplinary Treatment for Thoracic and Abdominopelvic Endometriosis via openalex

[39] Nafarelin vs. leuprolide acetate depot for endometriosis. Changes in bone mineral density and vasomotor symptoms. Nafarelin Study Group. via openalex

[40] One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial via openalex

[41] Oral contraceptive pills for endometriosis after conservative surgery: a systematic review and meta-analysis via openalex

[42] Oral contraceptives for pain associated with endometriosis via openalex

[43] Oral contraceptives for pain associated with endometriosis via openalex

[44] Oral contraceptives in the prevention of endometrioma recurrence: does the different progestins used make a difference? via openalex

[45] Oral Estroprogestins after Laparoscopic Surgery to Excise Endometriomas: Continuous or Cyclic Administration? Results of a Multicenter Randomized Study via openalex

[46] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex

[47] Postoperative administration of dienogest plus estradiol valerate versus levonorgestrel‐releasing intrauterine device for prevention of pain relapse and disease recurrence in endometriosis patients via openalex

[48] Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial via openalex

[49] Postoperative Levonorgestrel-Releasing Intrauterine System for Pelvic Endometriosis-Related Pain via openalex

[50] Postoperative levonorgestrel‐releasing intrauterine system versus oral contraceptives after gonadotropin‐releasing hormone agonist treatment for preventing endometrioma recurrence via openalex

[51] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[52] Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision via openalex

[53] Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis via openalex

[54] Progestagens and anti-progestagens for pain associated with endometriosis via openalex

[55] Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain via openalex

[56] Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial via openalex

[57] Recurrence rate of endometrioma after laparoscopic cystectomy: A comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo via openalex

[58] Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain via openalex

[59] Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life via openalex

[60] The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial via openalex

[61] The levonorgestrel-releasing intrauterine system and endometriosis staging via openalex

[62] Thoracic Endometriosis Syndrome: A Veritable Pandora’s Box via openalex

[63] Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone via openalex

[64] Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex

[65] Use of a progestogen only preparation containing desogestrel in the treatment of recurrent pelvic pain after conservative surgery for endometriosis via openalex

[66] Vaginal danazol for women with rectovaginal endometriosis and pain symptoms persisting after insertion of a levonorgestrel‐releasing intrauterine device via openalex

[67] W124103906 via openalex

[68] W2132077126 via openalex

[69] W2131027406 via openalex

[70] W2126339803 via openalex

[71] W2065895999 via openalex

[72] W2059444229 via openalex

[73] W2045089102 via openalex

[74] W2416488540 via openalex

[75] W2003246353 via openalex

[76] W1978085719 via openalex

[77] W4200472726 via openalex

[78] W1975317736 via openalex

[79] W4365920327 via openalex

[80] W6605101801 via openalex

[81] W6638359506 via openalex

[82] W6676396970 via openalex

[83] W6699591226 via openalex

[84] W6713180765 via openalex

[85] W6713534226 via openalex

[86] W6812233110 via openalex

[87] W6837363199 via openalex

[88] W2163315477 via openalex

[89] W1966091296 via openalex

[90] W2152955646 via openalex

[91] W2228635764 via openalex